Home » Healthcare Articles » Petrolene Le Roux Earns Membership With Stanford Who's Who
Petrolene Le Roux Earns Membership With Stanford Who's Who
Stanford Who's Who proudly announces the addition of Petrolene Le Roux to the exclusive network of premier professionals as a result of her phenomenal work in pharmaceuticals.
BLOEMFONTEIN, SOUTH AFRICA, November 25, 2011 /Stanford Who's Who/ -- Stanford Who's Who proudly announces the addition of Petrolene Le Roux to the exclusive network of premier professionals as a result of her phenomenal work in pharmaceuticals. As a Director GRO in South Africa with Parexel, as well as throughout her brilliant professional career, Petrolene has routinely demonstrated the passion, vision and perseverance necessary to be considered among the best.
Parexel is a is a growing, fast-paced, global Clinical Research Organization (CRO) that has helped bring to market 49 of the top 50 selling pharmaceuticals. The biopharmaceutical services company provides a range of capability in clinical research, medical communications services, consulting, and informatics and technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Among Petrolene's responsibilities are staff management as well as management coaching and development. During her collegiate career, she earned a Master of Business Administration degree in General Management from the University of the Free State. Petrolene is also a Registered Nurse. She is a member of the Association for Clinical Data Management and the South African Clinical Research Association.
To view more information on Petrolene Le Roux click here
To visit the Parexel website click here
--- Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Christine Curcio Stanford Who's Who Public Relations 410 Park Avenue, 15th Floor New York, NY USA 10022 Voice: (877) 650-2140 Website: Visit Our Website |
|
|
|
|
| HEALTHCARE ARCHIVE SEARCH |
|
|
| |
|